Stock Events

Middle East Pharmaceutical Industries Company (4016.SR) Q3 2024 Earnings

4016.SR -1.99%
5AugConfirmed
Q2 2024
Q3 2024
999
333
-333
-999

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Middle East Pharmaceutical Industries Company (4016.SR) will report earnings of for Q3 2024 on August 05, 2024.

0 Comments

Share your thoughts